Sign up for our upcoming webinar: Inflammation in a Translational Perspective
With just over a week to go, sign up for our upcoming webinar: Inflammation in a Translational Perspective. Make sure you seize the chance to gain knowledge from our distinguished experts.
Prof. Marianne Benn and Dr Frida Emanuelsson will introduce the event, followed by Prof. Christoph J. Binder discussing IgM antibodies. Dr Peter Libby will address inflammation’s crucial role in atherosclerosis. The webinar concludes with an interactive Q&A session, allowing attendees to engage with the experts.
Don’t wait, secure your spot and join the registrants who have already signed up!Go to registration page
Submit your abstract for the EAS Congress 2024 and apply for Young Investigator Fellowships and Travel Grants
Act promptly! This is your exclusive chance to be a part of the 92nd EAS Congress.
Additionally, we encourage you to explore the options available for Young Investigator Fellowships and Travel Grants. Further details can be found below.
The submission deadline is December 5, 2023.
We look forward to receiving your applications and look forward to seeing you in person in Lyon, France in May 26-29, 2024.Submit your abstractGrants and fellowships related to the EAS Congress
Featured Plenary Session from EAS Congress 2023: Redefining atherogenesis
This week, we’ve selected another plenary session for you: Redefining atherogenesis from the EAS Congress 2023 in Mannheim.
Tailor your learning experience to your schedule – begin your journey of lifelong learning with EAS Academy.
Click the image to access the lecture.Go to all recordings from the 2023 CongressFeatured Plenary Session: Redefining atherogenesis
Matthias Tschöp is Chief Executive Officer and Scientific Director of Helmholtz Zentrum München, Alexander von Humboldt Professor and Chair of Metabolic Diseases at Technical University of Munich, and serves as an adjunct professor at Yale University, USA. His research focuses on the molecular mechanisms of diabetes and obesity in order to discover new preventive and therapeutic approaches for the metabolic syndrome.
Recent research includes investigation of gut-brain communication as a key circuitry that regulates adiposity, glucose homeostasis and energy metabolism, as well as novel strategies for the early detection, individualised characterisation, and personalised therapy of metabolic dysfunction. His contributions include discovery of the hunger hormone ghrelin and gut hormone polyagonists that target both weight reduction and glycaemic control.
Renu Virmani is President of CVPath Institute, Gaithersburg, and Clinical Professor, Department of Pathology at Georgetown University; University of Maryland-Baltimore; George Washington University, and Vanderbilt University, USA.
Dr Virmani has revolutionised understanding of coronary atherosclerotic plaques and their role in sudden coronary death.
Dr. Virmani received her medical degree from Lady Hardinge Medical College, Delhi University, New Delhi, India. She is a member of the American Heart Association, and the US and Canadian Academy of Pathology, and is a Fellow of the American College of Cardiology. In 2021, Dr. Virmani was a recipient of the European Society of Cardiology Gold Medal.
Filip Swirski is the Arthur and Janet C. Ross Professor of Medicine (Cardiology) and Professor of Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, as well as Director of the Cardiovascular Research Institute. He obtained his PhD at McMaster University in Canada and undertook postdoctoral studies at Brigham and Women’s Hospital, Boston, before appointment as Professor at Harvard Medical School and Massachusetts General Hospital.
His research focuses on innate immunity and inflammation in cardiovascular disease. He uses in vivo models of acute and chronic inflammation relevant to cardiovascular and metabolic diseases, with specific emphasis on cell development, communication, and function. Recently, his focus has expanded to include lifestyle factors such as sleep, diet, and stress as critical modulators of cardiovascular health and hematopoiesis.
Stephanie Dimmeler is Director of the Institute of Cardiovascular Regeneration at Frankfurt University.
Her research focuses on the basic mechanisms underlying cardiovascular disease and vessel growth, with ongoing studies directed to elucidating epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs.
She is the recipient of numerous awards, most recently the Science4life award, the GlaxoSmithKline Award and the Madrid Award for Stem Cell Therapy in 2014, and presented the Thomas W. Smith Memorial Lecture at the Scientific Sessions of the American Heart Association in 2015.
Professor Dimmeler is editor of EMBO Molecular Medicine and associate editor of Circulation Research and the European Heart Journal.
The Certificate of Excellence in Lipidology – 2023 Update: accreditation you must achieve
The Certificate of Excellence in Lipidology – 2023 Update is a great way to become an expert in the field of lipids and their impact on health.
Many professionals are interested in this course, and you can still join. Plus, if you’re a full individual EAS member, you can get a special discount.Take the course